Published in Diabetes Care on April 15, 2015
Caloric Restriction, Exercise, and Glucoregulation in Humans (CREG) | NCT00777621
Effects of matched weight loss from calorie restriction, exercise, or both on cardiovascular disease risk factors: a randomized intervention trial. Am J Clin Nutr (2016) 0.80
Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss. Endocrinol Metab (Seoul) (2016) 0.78
High-intensity interval training: a review of its impact on glucose control and cardiometabolic health. Diabetologia (2016) 0.78
Effects of Weight Loss on Lean Mass, Strength, Bone, and Aerobic Capacity. Med Sci Sports Exerc (2016) 0.76
Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity. Endocrine (2016) 0.75
Inverse association between carbohydrate consumption and plasma adropin concentrations in humans. Obesity (Silver Spring) (2016) 0.75
The effect of meal frequency in a reduced-energy regimen on the gastrointestinal and appetite hormones in patients with type 2 diabetes: A randomised crossover study. PLoS One (2017) 0.75
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care (1999) 26.39
Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc (2002) 22.00
Standards of medical care in diabetes--2014. Diabetes Care (2014) 20.97
The biology of incretin hormones. Cell Metab (2006) 8.92
Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med (2000) 5.68
Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes (1992) 4.47
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab (2008) 4.19
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care (2000) 4.14
Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care (2007) 3.97
Seven-day recall and other physical activity self-reports in children and adolescents. Med Sci Sports Exerc (1993) 3.57
Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology (1995) 3.17
Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes (2001) 3.05
Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Diabetologia (2014) 3.01
Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem (1993) 2.93
Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am J Clin Nutr (2006) 2.57
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction. Int J Obes Relat Metab Disord (2001) 2.05
Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest (1988) 2.01
Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes (2005) 1.62
Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care (2010) 1.46
Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes (2010) 1.46
Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes. Diabetologia (2006) 1.33
The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to exercise training and diet in obesity. Am J Physiol Endocrinol Metab (2009) 1.16
Effect of GLP-1 on glucose transport and its cell signalling in human myocytes. Regul Pept (2005) 1.06
Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects. J Clin Endocrinol Metab (2010) 1.04
Decreased glucagon-like peptide 1 release after weight loss in overweight/obese subjects. Obes Res (2005) 1.02
Effect of 7-10 days of cycle ergometer exercise on skeletal muscle GLUT-4 protein content. J Appl Physiol (1985) (1995) 1.01
Prior exercise and postprandial incretin responses in lean and obese individuals. Med Sci Sports Exerc (2013) 0.87
GLP-1 (7-36) amide: effects on glucose transport and metabolism in rat adipose tissue. Horm Metab Res (1997) 0.86
Nutrient-stimulated glucagon-like peptide 1 release after body-weight loss and weight maintenance in human subjects. Br J Nutr (2006) 0.83
Reproducibility of multiple repeated oral glucose tolerance tests. Diabetes Res Clin Pract (2011) 0.78
Postprandial plasma incretin hormones in exercise-trained versus untrained subjects. Med Sci Sports Exerc (2014) 0.78